Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department

Respiratory Care

Volumn 56, Issue 6, 2011, Pages 761-770

  Sabato, Katie ^a   Ward, Priscilla ^a   Hawk, William ^b   Gildengorin, Virginia ^c   Asselin, Jeanette M ^d  

^a Department of Respiratory Care ^*  (United States)

^b Emergency Department   (United States)

^c Clinical and Translational Science Institute   (United States)

^d CHILDREN S HOSPITAL OAKLAND   (United States)

Author keywords

Aerosol; Albuterol; Asthma; Breath actuated; Bronchodilator; Clinical asthma score; Department; Emergency; Nebulizer; Pediatric

Indexed keywords

BRONCHODILATING AGENT; SALBUTAMOL; STEROID;

ARTICLE; ASTHMA; BREATH ACTUATED NEBULIZER; BREATHING RATE; CHILD; CONTROLLED STUDY; COUGHING; DRUG RESPONSE; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPERACTIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEBULIZATION; NEBULIZER; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SMALL VOLUME NEBULIZER; TREMOR; VOMITING;

ADMINISTRATION, INHALATION; ADOLESCENT; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INFANT; MALE; NEBULIZERS AND VAPORIZERS; TREATMENT OUTCOME;

EID: 79960691311     PISSN: 00201324     EISSN: 19433654     Source Type: Journal    
DOI: 10.4187/respcare.00142     Document Type: Article

References (36)

1. Rubin BK. Nebulizer therapy for children: the device-patient interface. Respir Care 2002;47(11):1314-1319.
2. Murakami G, Igarashi T, Adachi Y, Matsuno M, Adachi Y, Sawai M, et al. Measurement of bronchial hyperactivity in infants and preschool children using a new method. Ann Allergy 1990;64(4): 383-387.
3. Iles R, Lister P, Edmunds AT. Crying significantly reduces absorption of aerosolized drug in infants. Arch Dis Child 1999;81(2):163-165.
4. Marguet C, Couderc L, Le Roux P, Jeannot E, Lefay V, Mallet E. Inhalation treatments: errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. Pediatr Allergy Immunol 2001;12(4):224-230.
5. Crain EF, Weiss KB, Fagan MJ. Pediatric asthma care in US emergency departments: current practice in the context of the National Institutes of Health guidelines. Arch Pediatr Adolesc Med 1995; 149(8):893-901.
6. Katz RW, Kelly HW, Crowley MR, Grad R, McWilliams BC, Murphy SJ. Safety of continuous nebulized albuterol for bronchospasm in infants and children. Pediatrics 1993;92(2):666-669.
7. Stein J, Levitt MA. A randomized, controlled double-blinded trial of usual-dose versus high-dose albuterol via continuous nebulization in patients with acute bronchospasm. Acad Emerg Med 2003;10(1):31-36.
8. Shrestha M, Bidadi K, Gourlay S, Hayes J. Continuous vs intermittent albuterol, at high and low doses, in the treatment of severe acute asthma in adults. Chest 1996;110(1):42-47.
9. Alvine GF, Rodgers P, Fitzsimmons KM, Ahrens RC. Disposable jet nebulizers. How reliable are they? Chest 1992;101(2):316-319.
10. Hess D, Fisher D, Willians P, Pooler S, Kacmarek RM. Medication nebulizer performance: effects of diluent, volume, nebulizer flow and nebulizer brand. Chest 1996;110(2):498-505.
11. American Association for Respiratory Care. Aerosol consensus statement- 1991. Respir Care 1991;36(9):916-921.
12. Hess DR, Mitchell JP, Coppolo D, Nagel MW, Archer AD, Blacker R. Effects of nebulizers design on fine particle mass (abstract). Respir Care 1999;44(10):1289.
13. Hess DR, Horney D, Snyder T. Medication delivery: performance of eight small -volume hand held nebulizers: effects of diluent volume, gas flow rate and nebulizer model. Respir Care 1989;34(8):717-723.
14. Hess DR. Nebulizers: principles and performance. Respir Care 2000; 46(6):609-622.
15. Geller DE, Kesser B, Orlando FL. Comparison of drug output from 4 different reservoir-type nebulizers (abstract). Am J Respir Crit Care Med 2001;163(5):444.
16. Rau JL, Ari A, Restrepo RD. Performance comparison of nebulizer designs: constant output, breath-enhanced, and dosimetric. Respir Care 2004;49(2):174-179.
17. Pikarsky R, Farrell T, Acevedo R, Fascia W, Roman C. The delivery time, efficacy, and safety of beta agonist bronchodilator administration with the AERO-ECLIPSE breath actuated nebulizer "BAN" (abstract). Chest 2001;20(4):218S.
18. Leung K, Louca E, Coates A. Comparison of breath-enhanced to breath actuated nebulizers for rate, consistency, and efficiency. Chest 2004;126(5):1619-1627.
19. Anhoj J, Thorsson L, Bisgaard H. Lung deposition of inhaled drugs increases with age. Am J Respir Crit Care Med 2002;162(5):1819-1822.
20. Kao LC, Warburton D, Platzker AC, Keens TG. Effect of isoproterenol inhalation on airway resistance in chronic bronchopulmonary dysplasia. Pediatrics 1984;73(4):509-514.
21. Gutglass DJ, Hampers L, Roosevelt G, Teoh D, Nimmagadda SR, Krug SE. Undiluted albuterol aerosols in the pediatric emergency department. Pediatrics 2000;105(5):E67.
22. Schuh S, Johnson D, Stephens D, Callahan S, Canny G. Hospitalization patterns in severe acute asthma in children. Pediatr Pulmonol 1997;23(3):184-192.
23. Sabato K, Picchi P, Asselin J, Rutherford M. Use of a clinical asthma score (CAS) as the initial step in an asthma treatment algorithm in a pediatric emergency department (abstract). Respir Care 2002;47(9): 1072.
24. Reisner C, Kotch A, Dworkin G. Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized prospective study. Ann Allergy, Asthma Immunol 1995;75(1):41-47.
25. Lin RY, Sauter D, Newman T, Sirleaf J, Walters J, Tavavol M. Continuous versus intermittent albuterol nebulization in the treatment of acute asthma. Ann Emerg Med 1993;22(12):71-77.
26. Papo MC, Frank J, Thompson AE. A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children. Crit Care Med 1993;21(10):1479-1486.
27. Restrepo RD, Dickson SK, Rau JL, Gardenhire DS. An investigation of nebulized bronchodilator delivery using a pediatric lung model of spontaneous breathing. Respir Care 2006;51(1):56-61.
28. Virant FS. Effective once-daily administration of budesonide inhalation suspension by nebulizer with facemasks or mouthpieces for persistent asthma in infants and young children. Pediatrics 2002; 110(2):460-461.
29. Malone RA, Hollie MC, Glynn-Barnhart A, Nelson HS. Optimal duration of nebulized albuterol therapy. Chest 1993;104(4):1114-1118.
30. Mellon M, Leflein J, Walton-Bowen K, Cruz-Rivera M, Fitspatrick S, Smith J. Comparable efficacy of administration with face mask or mouthpiece of nebulized budesonide inhalation suspension for infants and young children with persistent asthma. Am J Respir Crit Care Med 2000;162(2 Pt 1):593-598.
31. Lowenthal D, Kattan M. Facemasks versus mouthpieces for aerosol treatment of asthmatic children. Pediatr Pulmonol 1992;14(3):192-196.
32. Rubin BK, Fink JB. Aerosol therapy for children. Respir Care Clin N Am 2001;7(2):175-213.
33. Amirav I, Newhouse MT. Aerosol therapy with valved holding chambers in young children: importance of the facemask seal. Pediatrics 2001;108(2):389-394.
34. Geller DE. Kesser B. Blowby vs facemask for nebulized drugs in young children (abstract). J Allergy Clin Immunol 2004;113(2):S32.
35. Everard ML, Clark AR, Milner AD. Drug delivery from nebulisers. Arch Dis Child 1992;67(5):586-591.
36. Rubin BK. Bye bye, blow-by (editorial). Respir Care 2007;52(8): 981.